Multiple sclerosis drug 'a landmark'
Posted: Thu Dec 22, 2016 1:01 am
On the news in the UK today
http://www.bbc.co.uk/news/health-38392548
Targets CD20-positive B-cells, which are implicated in the inflammatory and neurodegenerative processes of multiple sclerosis. Not sure about the risks or side-effects.
http://www.bbc.co.uk/news/health-38392548
Targets CD20-positive B-cells, which are implicated in the inflammatory and neurodegenerative processes of multiple sclerosis. Not sure about the risks or side-effects.